Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy

Lipids disorder is the principal cause of atherosclerosis and may present with several forms, according to blood lipoprotein prevalence. One of the most common forms is combined dyslipidemia, characterized by high levels of triglycerides and low level of high-density lipoprotein. Single lipid-loweri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantino, Nicola, Santoro, Francesco, De Gennaro, Luisa, Correale, Michele, Guastafierro, Francesca, Gaglione, Antonio, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317328/
https://www.ncbi.nlm.nih.gov/pubmed/28243111
http://dx.doi.org/10.2147/VHRM.S95044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317328/
https://www.ncbi.nlm.nih.gov/pubmed/28243111
http://dx.doi.org/10.2147/VHRM.S95044

Ejemplares similares